     In the United States Court of Federal Claims
                                    OFFICE OF SPECIAL MASTERS
                                        Filed: December 2, 2019

* * * * * *                *    *   *    *    *   *    *                 UNPUBLISHED
EMILY BRIGGS,                                          *
                                                       *                 No. 15-737V
                           Petitioner,                 *
v.                                                     *                 Special Master Gowen
                                                       *
SECRETARY OF HEALTH                                    *                 Meningococcal Conjugate
AND HUMAN SERVICES,                                    *                 (“Menactra”); Severe Aplastic
                                                       *                 Anemia; Stipulation.
                           Respondent.                 *
*    *   *   *    *   *    *    *   *    *    *   *    *

Richard Gage, Cheyenne WY, for petitioner.
Voris E. Johnson, United States Department of Justice, Washington, DC, for respondent.

                                      DECISION ON STIPULATION1

         On July 16, 2015, Emily Briggs (“petitioner”)2 filed a petition for compensation within
the National Vaccine Injury Compensation Program.3 Petition (ECF No. 1). Petitioner received
a meningococcal conjugate vaccine (“Menactra”) on August 2, 2012. Stipulation filed December
2, 2019 (ECF No. 93) (“Stipulation”) at ¶ 2. Petitioner alleged that she subsequently suffered the
injury of severe aplastic anemia, which she alleges was caused-in-fact by the Menactra vaccine.
Id. at ¶ 4. Petitioner further alleges that she experienced the residual effects of her injury for
more than six months. Id.


1
  Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this opinion contains a
reasoned explanation for the action in this case, I intend to post it on the website of the United States Court of
Federal Claims. The Court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. Before the opinion
is posted on the Court’s website, each party has 14 days to file a motion requesting redaction “of any information
furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or
confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly
unwarranted invasion of privacy.” Vaccine Rule 18(b). An objecting party must provide the Court with a proposed
redacted version of the opinion. Id. If neither party files a motion for redaction within 14 days, the opinion will
be posted on the Court’s website without any changes. Id.

2
  The petition was originally brought by Lauren Briggs on behalf of her then-minor daughter Emily. Emily
subsequently reached the age of majority and was substituted as the petitioner in this matter by the Court’s Order
issued September 26, 2017 (ECF No. 44).

3
 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine
Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012)
(Vaccine Act or the Act). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. §
300aa.
        On December 2, 2019, respondent filed a stipulation providing that a decision should be
entered awarding compensation to petitioner. Stipulation. Respondent denies that the Menactra
vaccine caused petitioner’s severe aplastic anemia and alleged residual effects, or any other
injury. Id. at ¶ 6. Maintaining their respective positions, the parties nevertheless now agree that
the issues between them shall be settled and that a decision should be entered awarding
compensation according to the terms of the stipulation attached hereto as Appendix A. Id. at ¶ 7.

        The stipulation awards:

        1) A lump sum of $35,000.00, in the form of a check payable to petitioner. This
           amount represents compensation for all damages that would be available under 42
           U.S.C. § 300aa-15(a).

       I adopt the stipulation as the decision of the Court in awarding damages. I hereby award
compensation in the amount and on the terms set forth therein. Accordingly, the Clerk of the
Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.4

        IT IS SO ORDERED.
                                                                       s/Thomas L. Gowen
                                                                       Thomas L. Gowen
                                                                       Special Master




4
 Entry of judgment is expedited by each party’s filing notice renouncing the right to seek review. Vaccine Rule
11(a).



                                                         2
